Suppr超能文献

通过全合成揭示 FD-895 的结构。

Structure of FD-895 revealed through total synthesis.

机构信息

Department of Chemistry and Biochemistry, University of Calfornia, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0358, USA.

出版信息

Org Lett. 2012 Nov 2;14(21):5396-9. doi: 10.1021/ol3023006. Epub 2012 Oct 16.

Abstract

The total synthesis of FD-895 was completed through a strategy that featured the use of a tandem esterification ring-closing metathesis (RCM) process to construct the 12-membered macrolide and a modified Stille coupling to append the side chain. These studies combined with detailed analysis of all four possible C16-C17 stereoisomers were used to confirm the structure of FD-895 and identify an analog with an enhanced subnanomolar bioactivity.

摘要

FD-895 的全合成是通过一种策略完成的,该策略的特点是使用串联酯化环 closing 复分解(RCM)过程构建 12 元大环内酯和修饰的 Stille 偶联来附加侧链。这些研究结合对所有四个可能的 C16-C17 立体异构体的详细分析,用于确认 FD-895 的结构并鉴定出具有增强的亚纳摩尔生物活性的类似物。

相似文献

1
Structure of FD-895 revealed through total synthesis.
Org Lett. 2012 Nov 2;14(21):5396-9. doi: 10.1021/ol3023006. Epub 2012 Oct 16.
2
Total synthesis of 13-demethyllyngbyaloside B.
Org Lett. 2013 Apr 5;15(7):1630-3. doi: 10.1021/ol400408w. Epub 2013 Mar 8.
3
Formal total synthesis of palmerolide A.
Chemistry. 2012 Nov 19;18(47):15202-6. doi: 10.1002/chem.201202324. Epub 2012 Oct 2.
4
Enantioselective synthesis of pladienolide B and truncated analogues as new anticancer agents.
Org Lett. 2013 Jul 19;15(14):3610-3. doi: 10.1021/ol401458d. Epub 2013 Jul 3.
10
Total Synthesis of (-)-Exiguolide.
Org Lett. 2015 Oct 2;17(19):4706-9. doi: 10.1021/acs.orglett.5b02162.

引用本文的文献

1
Yamaguchi esterification: a key step toward the synthesis of natural products and their analogs-a review.
Front Chem. 2024 Oct 11;12:1477764. doi: 10.3389/fchem.2024.1477764. eCollection 2024.
2
Stereochemical Control of Splice Modulation in FD-895 Analogues.
J Med Chem. 2023 May 25;66(10):6577-6590. doi: 10.1021/acs.jmedchem.2c01893. Epub 2023 May 8.
3
Detection and targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells.
Cell Rep Med. 2023 Mar 21;4(3):100962. doi: 10.1016/j.xcrm.2023.100962. Epub 2023 Mar 7.
4
Total Syntheses of Pladienolide-Derived Spliceosome Modulators.
Molecules. 2021 Sep 30;26(19):5938. doi: 10.3390/molecules26195938.
6
Total Synthesis of the Spliceosome Modulator Pladienolide B via Asymmetric Alcohol-Mediated syn- and anti-Diastereoselective Carbonyl Crotylation.
Angew Chem Int Ed Engl. 2021 Jun 14;60(25):13923-13928. doi: 10.1002/anie.202103845. Epub 2021 May 11.
7
Splice Modulation Synergizes Cell Cycle Inhibition.
ACS Chem Biol. 2020 Mar 20;15(3):669-674. doi: 10.1021/acschembio.9b00833. Epub 2020 Feb 17.
8
A Challenging Pie to Splice: Drugging the Spliceosome.
Angew Chem Int Ed Engl. 2017 Sep 25;56(40):12052-12063. doi: 10.1002/anie.201701065. Epub 2017 Aug 15.
9
Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia.
Stem Cell Investig. 2017 Feb 9;4:6. doi: 10.21037/sci.2017.01.06. eCollection 2017.
10
RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML.
Cell Stem Cell. 2016 Nov 3;19(5):599-612. doi: 10.1016/j.stem.2016.08.003. Epub 2016 Aug 25.

本文引用的文献

1
Biological validation that SF3b is a target of the antitumor macrolide pladienolide.
FEBS J. 2011 Dec;278(24):4870-80. doi: 10.1111/j.1742-4658.2011.08387.x. Epub 2011 Oct 31.
2
Synthesis of a pladienolide B analogue with the fully functionalized core structure.
Org Lett. 2011 Aug 5;13(15):3940-3. doi: 10.1021/ol201464m. Epub 2011 Jun 27.
4
Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing.
ACS Chem Biol. 2011 Jun 17;6(6):582-9. doi: 10.1021/cb100356k. Epub 2011 Mar 7.
5
Synthetic studies on the mycolactone core.
Org Biomol Chem. 2010 Nov 21;8(22):5159-65. doi: 10.1039/c0ob00540a. Epub 2010 Aug 19.
6
The pathobiology of splicing.
J Pathol. 2010 Jan;220(2):152-63. doi: 10.1002/path.2649.
7
Synthesis of the macrocyclic core of (-)-pladienolide B.
Org Lett. 2008 Jul 3;10(13):2821-4. doi: 10.1021/ol800946x. Epub 2008 May 30.
8
A synthetic entry to pladienolide B and FD-895.
Bioorg Med Chem Lett. 2007 Sep 15;17(18):5159-64. doi: 10.1016/j.bmcl.2007.06.094. Epub 2007 Jul 7.
9
Splicing factor SF3b as a target of the antitumor natural product pladienolide.
Nat Chem Biol. 2007 Sep;3(9):570-5. doi: 10.1038/nchembio.2007.16. Epub 2007 Jul 22.
10
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.
Nat Chem Biol. 2007 Sep;3(9):576-83. doi: 10.1038/nchembio.2007.18. Epub 2007 Jul 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验